To further comprehensively study CCR7 in de novo DLBCL and tFL, we immunohistochemically analyzed CCL19 and CCL21, the ligands of CCR7 [22,23,24,25,26,27], in our de novo DLBCL and tFL cohorts (n = 43). Here, CCL19 is linked to diffuse large B-cell lymphoma.